OpenVSafe by OpenVAERS
Search V-safe

EH3-31742-45477

2 vaccinations 5 coded responses 10 check-ins 5 free-text entries 0 call cases
Sex
Female
Age at first dose
05-11
ZIP prefix
212 / MD
Registered
2021-12-31
Relationship
Child or adolescent in my care
Guardian
QMF-15556-14644
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-12-09
    Dose 1 — Pfizer-BioNTech
  2. 2021-12-30
    Dose 2 — Pfizer-BioNTech
  3. 2021-12-31
    Registered in v-safe
  4. 2022-01-02
    Survey response — days 1–6 daily, dose 2, dependent
    MedDRA: Nasopharyngitis, Respiratory tract congestion — Feeling: Fair · Site: Pain · Fever
    Free text: Colds, mild congestion
    MedDRA releases: 2024-11 · check-in free text available
  5. 2022-01-03
    Survey response — days 1–6 daily, dose 2, dependent
    MedDRA: Nasopharyngitis, Respiratory tract congestion — Feeling: Good · Site: Pain
    Free text: Colds, mild congestion
    MedDRA releases: 2024-11 · check-in free text available
  6. 2022-01-05
    Survey response — days 1–6 daily, dose 2, dependent
    MedDRA: Nasopharyngitis, Respiratory tract congestion — Feeling: Good · Site: Pain
    Free text: Colds, mild congestion
    MedDRA releases: 2024-11 · check-in free text available
  7. 2022-01-06
    Survey response — day 7, dose 2, dependent
    MedDRA: Nasopharyngitis, Respiratory tract congestion — Feeling: Good
    Free text: Colds, mild congestion
    MedDRA releases: 2024-11 · check-in free text available
  8. 2022-01-14
    Health check-in — day 14, dose 2, dependent
    Feeling: Good
    Adult check-in
  9. 2022-01-20
    Health check-in — day 21, dose 2, dependent
    Feeling: Good
    Adult check-in
  10. 2022-01-27
    Health check-in — day 28, dose 2, dependent
    Feeling: Good
    Adult check-in
  11. 2022-02-03
    Health check-in — day 35, dose 2, dependent
    Feeling: Good
    Adult check-in
  12. 2022-02-10
    Health check-in — day 42, dose 2, dependent
    Feeling: Good
    Adult check-in
  13. 2022-04-07
    Survey response — 3 months, dose 2, dependent
    MedDRA: Headache, Oropharyngeal pain, Pyrexia — Feeling: Fair · Be unable to work or attend school
    Free text: Fever, sore throat, headache
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-12-09Pfizer-BioNTech No
22021-12-30Pfizer-BioNTech No

Free text

Release 10 — days 1–6 daily, dose 2, dependent

2022-01-02

Systemic reaction (other): Colds, mild congestion

2022-01-03

Systemic reaction (other): Colds, mild congestion

2022-01-05

Systemic reaction (other): Colds, mild congestion

Release 10 — day 7, dose 2, dependent

2022-01-06

Systemic reaction (other): Colds, mild congestion

Release 11 — 3 months, dose 2, dependent

2022-04-07

Symptoms: Fever, sore throat, headache

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDHeadache · · ✓
SDOropharyngeal pain · · ✓
SDPyrexia · · ✓
SRONasopharyngitis · · ✓
SRORespiratory tract congestion · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release